Randomised, double-blind trial of omega-3 polyunsaturated fatty acids (n-3 PUFA) in patients undergoing percutaneous coronary interventions.
Phase of Trial: Phase III
Latest Information Update: 26 May 2011
At a glance
- Drugs Omega-3-acid ethyl esters (Primary) ; Aspirin; Clopidogrel
- Indications Coronary artery disease
- Focus Pharmacodynamics
- Acronyms OMEGA-PCI Clot
- 05 Nov 2010 New trial record.